Prothena Corp Public (PRTA) Return on Sales (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Return on Sales of 0.01% for Q1 2026, up 22.0% year-over-year from 0.01% in Q1 2025, and up 100.06% quarter-over-quarter from 10.26% in Q4 2025.
Prothena Corp Public (PRTA) Return on Sales (2012 - 2026) Analysis & Trends
Prothena Corp Public's Return on Sales history runs 15 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Sales rose 22.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.03% (down 2.0% YoY), while the FY2025 annual figure was 0.25%, down 24.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.01%, up from 10.26% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q1 2026, with the low at 14.45% in Q1 2024.
- The 5-year median for Return on Sales is 0.27% (2024), against an average of 1.74%.
- The sharpest annual moves came in 2024 and 2025: Return on Sales tumbled 1423 bps in 2024, then surged 1423 bps in 2025.
- Prothena Corp Public's Return on Sales stood at 0.0% in 2022, then slumped by 168003 bps to 2.14% in 2023, then surged by 87 bps to 0.27% in 2024, then plunged by 3656 bps to 10.26% in 2025, then surged by 100 bps to 0.01% in 2026.
- Business Quant data shows PRTA's Return on Sales at 0.01% in Q1 2026, 10.26% in Q4 2025, and 0.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | -0.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18% |
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | -10.26% |
| Sep 30, 2025 | -0.15% |
| Jun 30, 2025 | -0.28% |
| Mar 31, 2025 | -0.21% |
| Dec 31, 2024 | -0.27% |
| Sep 30, 2024 | -0.61% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | -14.45% |
| Dec 31, 2023 | -2.14% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.14% |
| Mar 31, 2023 | -0.22% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.30% |
| Jun 30, 2022 | -0.31% |
| Mar 31, 2022 | -0.31% |
| Dec 31, 2021 | -0.28% |
| Sep 30, 2021 | 0.01% |